Human bocavirus

Overview

File:Human bocavirus 1 pneumonia.jpg

Human bocavirus 1 pneumonia in a chest X-ray

Human bocavirus (HBoV) is a member of the Parvoviridae family, specifically classified under the genus Bocaparvovirus. It is a small, non-enveloped DNA virus that has been associated with respiratory tract infections, particularly in children. The virus was first identified in 2005 and has since been recognized as a significant pathogen in pediatric respiratory illnesses.

Virology

Human bocavirus is a single-stranded DNA virus with a genome size of approximately 5.3 kilobases. The virus is characterized by its non-enveloped icosahedral capsid. The genome encodes for three major proteins: NS1, NP1, and VP1/VP2. The NS1 protein is involved in viral replication, while NP1 is unique to bocaviruses and plays a role in the regulation of gene expression. The VP1/VP2 proteins form the capsid structure.

Epidemiology

HBoV is a globally distributed virus, with infections reported in various regions including North America, Europe, and Asia. It primarily affects young children, with the highest incidence observed in those under the age of two. The virus is often detected in respiratory secretions, and transmission is believed to occur via respiratory droplets.

Clinical Manifestations

Infections with human bocavirus can range from asymptomatic to severe respiratory illness. Common symptoms include cough, wheezing, and difficulty breathing. In some cases, HBoV infection can lead to pneumonia and acute bronchiolitis. The virus has also been detected in cases of gastroenteritis, although its role in gastrointestinal disease is less clear.

Diagnosis

Diagnosis of HBoV infection is typically achieved through polymerase chain reaction (PCR) testing of respiratory specimens. Serological assays can also be used to detect antibodies against the virus, although these are less commonly employed in clinical practice.

Treatment and Prevention

There is currently no specific antiviral treatment for human bocavirus infections. Management is primarily supportive, focusing on alleviating symptoms and ensuring adequate oxygenation in severe cases. Preventive measures include standard infection control practices such as hand hygiene and respiratory etiquette.

Research Directions

Ongoing research is focused on understanding the pathogenesis of HBoV, its role in co-infections, and the development of potential vaccines. Studies are also exploring the virus's impact on the immune system and its interactions with other respiratory pathogens.

Related pages

• Parvoviridae
• Respiratory tract infection
• Pneumonia
• Viral infection